BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27390962)

  • 1. A plausible causal link between antiretroviral therapy and increased blood pressure in a sub-Saharan African setting: A propensity score-matched analysis.
    Nduka CU; Stranges S; Bloomfield GS; Kimani PK; Achinge G; Malu AO; Uthman OA
    Int J Cardiol; 2016 Oct; 220():400-7. PubMed ID: 27390962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of body fat changes in mediating the effects of antiretroviral therapy on blood pressure in HIV-infected persons in a sub-Saharan African setting.
    Nduka CU; Uthman OA; Kimani PK; Malu AO; Stranges S
    Infect Dis Poverty; 2016 Jun; 5(1):55. PubMed ID: 27245216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy.
    Baekken M; Os I; Sandvik L; Oektedalen O
    J Hypertens; 2008 Nov; 26(11):2126-33. PubMed ID: 18854751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between highly active antiretroviral therapy and selected cardiovascular disease risk factors in sub-Saharan Africa: a systematic review and meta-analysis protocol.
    Dimala CA; Blencowe H
    BMJ Open; 2017 Mar; 7(3):e013353. PubMed ID: 28279997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension prevalence and Framingham risk score stratification in a large HIV-positive cohort in Uganda.
    Mateen FJ; Kanters S; Kalyesubula R; Mukasa B; Kawuma E; Kengne AP; Mills EJ
    J Hypertens; 2013 Jul; 31(7):1372-8; discussion 1378. PubMed ID: 23615323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients.
    Palacios R; Santos J; García A; Castells E; González M; Ruiz J; Márquez M
    HIV Med; 2006 Jan; 7(1):10-5. PubMed ID: 16313287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of increased blood pressure and hypertension risk among people living with HIV on antiretroviral therapy: a systematic review with meta-analysis.
    Nduka CU; Stranges S; Sarki AM; Kimani PK; Uthman OA
    J Hum Hypertens; 2016 Jun; 30(6):355-62. PubMed ID: 26446389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003.
    Seaberg EC; Muñoz A; Lu M; Detels R; Margolick JB; Riddler SA; Williams CM; Phair JP;
    AIDS; 2005 Jun; 19(9):953-60. PubMed ID: 15905677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings.
    Robertson K; Kumwenda J; Supparatpinyo K; Jiang JH; Evans S; Campbell TB; Price RW; Murphy R; Hall C; Marra CM; Marcus C; Berzins B; Masih R; Santos B; Silva MT; Kumarasamy N; Walawander A; Nair A; Tripathy S; Kanyama C; Hosseinipour M; Montano S; La Rosa A; Amod F; Sanne I; Firnhaber C; Hakim J; Brouwers P;
    J Neurovirol; 2011 Oct; 17(5):438-47. PubMed ID: 21786076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of HIV status and antiretroviral therapy on blood pressure.
    Wilson SL; Scullard G; Fidler SJ; Weber JN; Poulter NR
    HIV Med; 2009 Jul; 10(6):388-94. PubMed ID: 19490176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effect of HAART on blood pressure in HIV-infected individuals.
    Grandominico JM; Fichtenbaum CJ
    HIV Clin Trials; 2008; 9(1):52-60. PubMed ID: 18215982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Child-focused state cash transfers and adolescent risk of HIV infection in South Africa: a propensity-score-matched case-control study.
    Cluver L; Boyes M; Orkin M; Pantelic M; Molwena T; Sherr L
    Lancet Glob Health; 2013 Dec; 1(6):e362-70. PubMed ID: 25104601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
    Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
    AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries.
    Greig J; Casas EC; O'Brien DP; Mills EJ; Ford N
    AIDS; 2012 Jul; 26 Suppl 1():S31-7. PubMed ID: 22781173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of health insurance and facility quality improvement on blood pressure in adults with hypertension in Nigeria: a population-based study.
    Hendriks ME; Wit FW; Akande TM; Kramer B; Osagbemi GK; Tanovic Z; Gustafsson-Wright E; Brewster LM; Lange JM; Schultsz C
    JAMA Intern Med; 2014 Apr; 174(4):555-63. PubMed ID: 24534947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated blood pressure in HIV-infected individuals receiving highly active antiretroviral therapy.
    Chow DC; Souza SA; Chen R; Richmond-Crum SM; Grandinetti A; Shikuma C
    HIV Clin Trials; 2003; 4(6):411-6. PubMed ID: 14628284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G; Lewden C; Spire B; Salmon D; Brun-Vézinet F; Duong M; Allavena C; Leport C; Salamon R;
    HIV Med; 2007 Apr; 8(3):164-70. PubMed ID: 17461860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of highly active antiretroviral therapy on the survival of HIV-infected adult patients in urban slums of Kenya.
    Muhula SO; Peter M; Sibhatu B; Meshack N; Lennie K
    Pan Afr Med J; 2015; 20():63. PubMed ID: 26090021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa.
    Lawn SD; Myer L; Bekker LG; Wood R
    BMC Infect Dis; 2006 Mar; 6():59. PubMed ID: 16551345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.
    Seyler C; Toure S; Messou E; Bonard D; Gabillard D; Anglaret X
    Am J Respir Crit Care Med; 2005 Jul; 172(1):123-7. PubMed ID: 15805184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.